Latest filings (excl ownership)
8-K
Sanara MedTech Inc. Announces $55 Million Debt Facility
18 Apr 24
ARS
2023 FY
Annual report to shareholders
15 Apr 24
DEFA14A
Additional proxy soliciting materials
15 Apr 24
DEF 14A
Definitive proxy
15 Apr 24
PRE 14A
Preliminary proxy
5 Apr 24
8-K
Departure of Directors or Certain Officers
5 Apr 24
8-K
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
25 Mar 24
10-K
2023 FY
Annual report
25 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
22 Mar 24
8-K
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
22 Feb 24
8-K
Sanara MedTech Inc. Announces Third Quarter 2023 Results
13 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Regulation FD Disclosure
19 Sep 23
8-K
Regulation FD Disclosure
16 Aug 23
8-K
Sanara MedTech Inc. Announces Second Quarter 2023 Results
14 Aug 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
D
$3.00 mm in equity, sold $3.00 mm, 1 investor
11 Aug 23
8-K
Sanara MedTech Inc. Announces the Acquisition of Certain Assets Related to its Collagen Products Business
2 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
6 Jun 23
8-K
Sanara MedTech Inc. Announces First Quarter 2023 Results
15 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
8-K
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2022 Results
20 Mar 23
10-K
2022 FY
Annual report
20 Mar 23
8-K
Entry into a Material Definitive Agreement
24 Feb 23
424B5
Prospectus supplement for primary offering
24 Feb 23
8-K
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2022
22 Feb 23
8-K
Regulation FD Disclosure
16 Dec 22
8-K
Departure of Directors or Certain Officers
6 Dec 22
8-K
Regulation FD Disclosure
30 Nov 22
8-K/A
Results of Operations and Financial Condition
15 Nov 22
8-K
Sanara MedTech Inc. Announces Third Quarter 2022 Results
14 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
S-8
Registration of securities for employees
26 Aug 22
8-K
Sanara MedTech Inc. Announces Second Quarter 2022 Results
15 Aug 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
8-K/A
Completion of Acquisition or Disposition of Assets
15 Jul 22
Latest ownership filings
4
Jacob A. Waldrop
16 Apr 24
3
Jacob A. Waldrop
16 Apr 24
4
Zachary B. Fleming
11 Mar 24
4
Michael D. McNeil
11 Mar 24
4
Zachary B. Fleming
5 Mar 24
4
Michael D. McNeil
5 Mar 24
4
Zachary B. Fleming
5 Feb 24
4
Michael D. McNeil
5 Feb 24
4
Zachary B. Fleming
3 Jan 24
4
Zachary B. Fleming
22 Sep 23
4
ERIC D TANZBERGER
5 Jun 23
4
JAMES W STUCKERT
5 Jun 23
4
Robert Andrew DeSutter
5 Jun 23
4
Sara N Ortwein
5 Jun 23
4
Eric D Major
5 Jun 23
4
Ronald T Nixon
5 Jun 23
4
Ann Beal Salamone
5 Jun 23
4
Roszell Mack III
5 Jun 23
3
Eric D Major
5 Jun 23
4
Michael D. McNeil
14 Apr 23
4
Zachary B. Fleming
21 Mar 23
4
Rebecca E McMahon
21 Mar 23
4
Michael D. McNeil
21 Mar 23
4
Rebecca E McMahon
6 Mar 23
4
Michael D. McNeil
6 Mar 23
4
Zachary B. Fleming
6 Mar 23
4
Zachary B. Fleming
6 Dec 22
4
Shawn M. Bowman
6 Dec 22
4
Michael D. McNeil
6 Dec 22
4
Zachary B. Fleming
10 Nov 22
4
Zachary B. Fleming
8 Nov 22
4
Zachary B. Fleming
4 Nov 22
4
Shawn M. Bowman
26 Sep 22
4
Roszell Mack III
8 Jul 22
4
Robert Andrew DeSutter
8 Jul 22
4
ERIC D TANZBERGER
8 Jul 22
4
Kenneth E Thorpe
8 Jul 22
4
Sara N Ortwein
8 Jul 22
4
JAMES W STUCKERT
8 Jul 22
4
Ronald T Nixon
8 Jul 22